Werner Verbiest is Global Head of Janssen Diagnostics, comprising the legacy organizations of Virco, Veridex, and Johnson and Johnson’s Companion Diagnostics Center of Excellence. Janssen Dx focuses on personalized medicine within Janssen, incorporating therapeutic, diagnostic and real world data/health information technology solutions to improve patient outcomes.
Werner joined Johnson & Johnson in 1992 with the International Clinical R&D group of the Janssen Research Foundation, where he was active in HIV drug development and Hepatitis B vaccine development. In 1997, Werner joined Virco, as Project Director, Business Development. He was promoted to Managing Director, Virco Ireland in 2002 and became General Manager in 2004.
In his current role as Global Head, Werner plays a leading role in advocating for and actualizing a personalized medicine approach both within and outside of Johnson & Johnson, including several board seats as EPEMED, AdvaMedDx and PMC.